We are live on ! Find out more
FFVM

Founders Fund VI Management Portfolio holdings

AUM $45.8K
1-Year Est. Return 58.63%
This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
-58.63%
3 Year Est. Return
-80.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7M
AUM Growth
-$459K
Cap. Flow
+$10.4K
Cap. Flow %
0.08%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
+$140K

Top Sells

Rank Stock Value
1
AMTI
Applied Molecular Transport Inc. Common Stock
AMTI
+$130K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$25.2B
$12.6M 98.63%
1,119,489
– –
CYTH
2
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$175K 1.37%
+110,023
New +$140K
AMTI
3
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
– –
-826,607
Closed -$130K

Similar funds

SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
MI
Motiv8 Investments Port St. Lucie, Florida $183K AUM 15.06% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return

Founders Fund VI Management's Q4 2023 Portfolio in Review

As of Q4 2023, Founders Fund VI Management held 3 positions worth $12.7M, down 3.5% from $13.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Founders Fund VI Management's Q4 2023 filing shows 1 new and 1 closed positions. Its largest new stake was Cyclo Therapeutics, Inc. Common Stock: 110,023 shares worth $175K. The largest sale was Applied Molecular Transport Inc. Common Stock, an estimated $130K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Founders Fund VI Management's largest Q4 2023 buy was Cyclo Therapeutics, Inc. Common Stock: 110,023 shares worth $175K.
  • Founders Fund VI Management fully exited Applied Molecular Transport Inc. Common Stock in Q4 2023, selling an estimated $130K.
  • Founders Fund VI Management's ten largest holdings make up 100% of its $12.7M portfolio in Q4 2023.
  • Founders Fund VI Management opened 1 new position and closed 1 in Q4 2023.
  • Founders Fund VI Management's portfolio value fell 3.5% quarter-over-quarter to $12.7M.

Based on Founders Fund VI Management's 13F filing for Q4 2023, filed 14 Feb 2024.